Jeffrey Sivik

Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice

Kathleen M. Kokolus, Ying Zhang, Jeffrey Sivik et al. · OncoImmunology · 2017 · 178 citations · Full text

Life Sciences, Immunology, Oncology +17

Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice

Nicole M Agostino, Vernon M. Chinchilli, Christopher J. Lynch et al. · Journal of Oncology Pharmacy Practice · 2010 · 159 citations

Medicine, Pharmacology, Pharmacotherapy +17

Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia

Bei Jia, Chenchen Zhao, Kevin Rakszawski et al. · Cancer Research · 2019 · 57 citations · Full text

Life Sciences, Immunology, Oncology +17

Personalized Dosing via Pharmacokinetic Monitoring of 5-Fluorouracil Might Reduce Toxicity in Early- or Late-Stage Colorectal Cancer Patients Treated With Infusional 5–Fluorouracil-Based Chemotherapy Regimens

C. Leah B. Kline, Angelique Schiccitano, Junjia Zhu et al. · Clinical Colorectal Cancer · 2013 · 40 citations

Pharmacy, Oncology, Pharmacokinetics +17

Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up

Joseph J Kishel, Jeffrey Sivik · Journal of Oncology Pharmacy Practice · 2008 · 38 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16